Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
September 10, 2019
Patent Application Number
15943229
Date Filed
April 2, 2018
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention relates to, inter alia, combinations, methods, compositions, and oral dosage forms of a FAK inhibitor and a MEK inhibitor, for treating abnormal cell growth (e.g., cancer).
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
